API-Bioxal, 886 mg/g Powder for In-hive Use

Riik: Suurbritannia

keel: inglise

Allikas: VMD (Veterinary Medicines Directorate)

Toimeaine:

Oxalic acid dihydrate

Saadav alates:

Chemicals Laif S.P.A

ATC kood:

QP53AG03

INN (Rahvusvaheline Nimetus):

Oxalic acid dihydrate

Ravimvorm:

Inhalation vapour, solution

Retsepti tüüp:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Terapeutiline rühm:

Honey bees

Terapeutiline ala:

Ectoparasiticide

Volitamisolek:

Authorized

Loa andmise kuupäev:

2015-09-08

Toote omadused

Revised: August 2021
AN: 00127/2021 and 00128/2021
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
API-Bioxal 886 mg/g powder for in-hive use
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each g contains:
ACTIVE SUBSTANCE:
Oxalic acid dihydrate 886 mg (equivalent to 632.70 mg of Oxalic acid)
EXCIPIENTS:
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Powder for in-hive use.
White fine powder.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Honey bees _(Apis mellifera_).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of varroosis caused by _Varroa destructor _in honey bees
_(Apis mellifera_).
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
For greatest efficacy, the product should only be used when the
quantity of brood in
the colony is non-existent or at its lowest levels. Oxalic acid does
not penetrate wax
so will not kill mites within capped brood and therefore the presence
of brood may
noticeably reduce the efficacy of the product. As such, the product
should be used in
winter or following manipulation of the colony to produce a broodless
state in summer
(e.g. by queen caging).
With regard to summer treatments following queen caging, highest
levels of efficacy
were achieved when a caging period of at least 25 days was used, at
which point the
colonies were completely broodless. Despite proper treatment,
seriously damaged
colonies may not survive due to the effects of varroa infestation.
Integrated Pest Management Programme
The efficacy may vary between colonies due to the conditions of use
(residue
presence of brood, temperature, reinfestations etc.). The product
should therefore be
Revised: August 2021
AN: 00127/2021 and 00128/2021
Page 2 of 5
used as a treatment amongst others within an Integrated Pest
Management program,
and mite drop regularly monitored.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Administer the treatment without supers. All colonies in the same
apiary should be